These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 1154901)

  • 1. [Potency testing of inactivated rabies vaccines with the antibody binding test in comparison with the NIH and habel test(author's transl)].
    Oei HL; Krauss H
    Zentralbl Bakteriol Orig A; 1975; 231(1-3):1-14. PubMed ID: 1154901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of the single radial immunodiffusion test as a replacement for the NIH mouse potency test for rabies vaccine.
    Fitzgerald EA; Needy CF
    Dev Biol Stand; 1986; 64():73-9. PubMed ID: 3098606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Questions concerning the potency of rabies vaccine.
    Crick J; Brown F
    Dev Biol Stand; 1978; 40():179-82. PubMed ID: 355012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of the antibody assay in immunized mice for the determination of rabies vaccine potency.
    Fitzgerald EA; Gallagher M; Hunter WS; Seligmann EB
    Dev Biol Stand; 1978; 40():183-6. PubMed ID: 355013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison studies on potency tests for rabies vaccines.
    Wiktor TJ; Atanasiu P; Bahmanyar M; Boegel K; Cox JH; Diaz AM; Fitzgerald EA; Kuwert E; Netter R; Selimov M; Turner G; van Steenis G
    Dev Biol Stand; 1978; 40():171-8. PubMed ID: 355011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A potency test which simulates natural exposure for measuring post-exposure activity of rabies vaccines. A proposal for preparing a relevant international reference preparation.
    Bijlenga G
    Dev Biol Stand; 1978; 40():203-8. PubMed ID: 567153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and evaluation of alternative testing methods for the in vivo NIH potency test used for the quality control of inactivated rabies vaccines.
    Rooijakkers E; Groen J; Uittenbogarrd J; van Herwijnen J; Osterhaus A
    Dev Biol Stand; 1996; 86():137-45. PubMed ID: 8785943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Counterimmunoelectrophoresis technique for determining the antigenic potency of rabies vaccine].
    Miceli G; Torroba JE; Diaz AM
    Rev Inst Med Trop Sao Paulo; 1993; 35(6):543-50. PubMed ID: 7997759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single radial immunodiffusion assays for the standardization of the antigenic content of rabies vaccines.
    Ferguson M; Seagroatt V; Schild GC
    Dev Biol Stand; 1986; 64():81-6. PubMed ID: 3098607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of the usefulness of the antibody binding test for the estimation of the potency of the rabies vaccine].
    Wysokińska T; Janaszek W; Rymkiewicz D
    Przegl Epidemiol; 1994; 48(3):297-9. PubMed ID: 7938635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Properties and potency of a rabies vaccine produced on the brain matter of young goats and inactivated by beta-propiolactone].
    Mansour AB; Abrous M
    Dev Biol Stand; 1978; 41():217-24. PubMed ID: 753652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antigenic determination of human anti-rabies vaccine against viral street strains common in the wild animal population in Poland].
    Seroka D
    Med Dosw Mikrobiol; 1994; 46(4):331-47. PubMed ID: 7541494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A simple immuno-capture ELISA to estimate rabies viral glycoprotein antigen in vaccine manufacture.
    Nagarajan T; Reddy GS; Mohana Subramanian B; Rajalakshmi S; Thiagarajan D; Tordo N; Jallet C; Srinivasan VA
    Biologicals; 2006 Mar; 34(1):21-7. PubMed ID: 16188454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Standardization of methods used for testing the safety of tissue culture rabies vaccines.
    Romanova LN; Polyushkina GS
    Dev Biol Stand; 1978; 40():209-13. PubMed ID: 680394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative study of methods for controlling the immunogenicity of rabies vaccines].
    Dilovski M; Antonov P
    Vet Med Nauki; 1982; 19(7):66-72. PubMed ID: 6760532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [NIH potency tests with inactivated rabies vaccines (author's transl)].
    Barth R; Jaeger O
    Zentralbl Bakteriol B; 1979; 169(5-6):488-94. PubMed ID: 545949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potency testing of diploid-cell rabies vaccine and correlation with immunogenicity.
    Tint H; Rosanoff EI
    Dev Biol Stand; 1978; 40():195-201. PubMed ID: 680393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of an animal rabies vaccine by use of two types of potency tests.
    Baer GM
    Am J Vet Res; 1997 Aug; 58(8):837-40. PubMed ID: 9256966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Potency testing of inactivated rabies vaccines. Problems posed by the use of the Habel test].
    Aubert MF; Andral L
    Comp Immunol Microbiol Infect Dis; 1979; 1(4):341-9. PubMed ID: 318239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Value determination of rabies vaccine according to Hempt in the Habel- and Plantar test according to Krause].
    Glathe H
    Z Gesamte Hyg; 1966 Jun; 12(6):449-54. PubMed ID: 5964479
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.